| pubmed-article:21118737 | pubmed:abstractText | Vancomycin alternatives, including clindamycin, have in vitro activity against current strains of methicillin-resistant Staphylococcus aureus (MRSA), but clinical evidence of their effectiveness is needed. | lld:pubmed |
